After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Have you or someone you love been diagnosed with Alzheimer’s disease? This clinical trial may be just what you.

Researchers at the Francis Crick Institute and UCL have shown that genetic messages are misplaced in nerve cells in a model ...

More information: Jeffrey L. Cummings et al, Alzheimer's disease drug development pipeline: 2025, Alzheimer's & Dementia: Translational Research & Clinical Interventions (2025). DOI: 10.1002/trc2 ...

Clinical trials are underway or completed for at least seven Alzheimer’s vaccines designed to harness the immune system to rid the brain of the disease-related proteins beta amyloid or tau, a ...

In clinical trials for Alzheimer’s drugs, genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.

Dublin, July 02, 2024 (GLOBE NEWSWIRE) -- The "Dementia - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The analyst's clinical trial ...

- Commonly used Alzheimer's clinical trial exclusion criteria have the potential to disproportionately affect African Americans and Hispanics/Latinos, ...

Senile Dementia Clinical Trial Pipeline Highlights 2019 - Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company - ResearchAndMarkets.com June 14, 2019 11:43 AM Eastern ...

If someone begins a clinical trial, they have the option to discontinue with the trial at any time for any reason (for example, if you don’t feel comfortable or experience unwanted side effects).

The annual review of Alzheimer's clinical trials reports 182 active trials and 138 drugs in development, with a marked rise in early-phase studies and new entries to the pipeline.

Frontotemporal Dementia Clinical Trial Pipeline Highlights 2019 - Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company - ResearchAndMarkets.com June 13, 2019 02:43 PM ...